- £39.08m
- £37.36m
- £14.86m
- 62
- 17
- 89
- 57
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22.7 | 19.4 | 17.8 | 17 | 14.9 |
Cost of Revenue | |||||
Gross Profit | 4.38 | 2.85 | 3.81 | 4.78 | 3.5 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 21.7 | 19.9 | 17.1 | 15.9 | 14.8 |
Operating Profit | 1.02 | -0.568 | 0.686 | 1.11 | 0.035 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.02 | -0.602 | 0.644 | 1.08 | 0.009 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.885 | -0.761 | 0.685 | 1.17 | -0.044 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.885 | -0.761 | 0.685 | 1.17 | -0.044 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.885 | -0.761 | 0.685 | 1.17 | -0.044 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.054 | -0.048 | 0.042 | 0.07 | -0.003 |
Dividends per Share |